Mass production of placenta stem cells gets FDA approval – RT
| RT The US Food and Drug Administration has granted approval to Pluristem Therapeutics to mass produce therapeutic human-placenta-derived stem cell products within its commercial-scale manufacturing facility in Haifa, Israel. Pluristem’s Placental Expanded … FDA approves Israel-developed stem cell ‘factory’ for researchThe Times of Israel |
